BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 10, 2004
View Archived Issues
Selective GABA-A alpha3 receptor subtype agonist and diazepam show comparable effects in vivo
Read More
Neurocognitive benefits of methylphenidate in children who survive leukemia or brain tumors
Read More
Triage D-Dimer test cleared for use
Read More
European MAA submitted for Cubicin
Read More
NT-proBNP test cleared for use in two new indications
Read More
Buprenorphine analogue inhibits morphine-induced behavioral sensitization in mice
Read More
Nonpeptide orally available SK channel blockers for gastrointestinal motility disorders
Read More
Orally active cathepsin inhibitor effective against osteoporosis in vivo
Read More
Study on effects of RWJ-333369 support use of chronic models in antiepileptic drug discovery
Read More
Endovasc reports positive drug delivery findings
Read More
PhytoMedical enters CRADA to synthesize type 2 diabetes compounds
Read More
FibroGen reports positive findings for oral anemia therapy FG-2216
Read More
Fast track status for AMG-531 in immune thrombocytopenic purpura
Read More
AMG-706 awarded fast track status
Read More
Maxygen announces new development program, reprioritizes pipeline
Read More
CytRx investigates two distinct approaches for treatment of ALS
Read More
Preclinical studies support the use of MLN-518 in AML
Read More
New data on the neurophysiological effects of talampanel in humans
Read More
Update on the safety and antiepileptic effects of retigabine
Read More
TaiGen claims novel series of chemokine receptor modulators
Read More
New benzimidazole derivatives for CNS disorders under study at NeuroSearch
Read More
Novartis researchers design new immunosuppressant and antiinflammatory agents
Read More
Scientists at Predix report 5-HT2B receptor modulators for CNS and vascular disorders
Read More
New compounds acting on melanocortin receptors reported by SCRAS
Read More
Gamma-secretase inhibitors identified at Merck
Read More
Aryplase submitted for European approval
Read More
Clinical responses seen in phase I/II study of Humax-CD20 in NHL
Read More
BioVisioN spins off ImVisioN
Read More
Medarex and PharmAthene to develop and commercialize MDX-1303
Read More
Topline results from phase III study of edifoligide for peripheral bypass graft
Read More
LAB International plans phase II study of GHRH analogue
Read More
Endovasc plans phase III trial for Liprostin in 2005
Read More